myrImager
Drug-screening on contractile tissue
The myrImager, developed by Universitätsmedizin Göttingen (UMG) & myriamed, is a novel video-optical high-throughput imaging platform. It complements SYNENTEC’s imaging device portfolio and is widely used in drug development and screening.
Together with myriamed 48-well 3D cell/tissue culture plates, it enables advanced imaging of iPSC-derived tissue models for research and ICH hERG–aligned screening.
Using poleDance software, users benefit from flexible scheduling, custom plate layouts, and precise readouts of pole movement kinetics.
Discover all the advantages
Best-in-class tissue imager for functional kinetics
The myrImager was developed based on myriamed’s unrivaled expertise in pluripotent stem cell-based tissue formulations and their phenotypic analyses. It images heart muscle, skeletal muscle and connective tissue formulations prepared in myriamed proprietary myrPlates and performs contraction kinetics (force-time curves) e.g. for funtional IC50/EC50 studies.
SYNENTEC as expert in microscopic solutions for automated high-content screens took on the challenge to re-engineer the myrImager to develop it into a unique product for the stem cell & drug-screening community.
The myrImager operates independently from SYNENTEC’s YT Image Analysis Software on a novel data evaluation platform. Powered by the innovative poleDance software, it offers advanced capabilities such as measuring pole movement kinetics with flexible scheduling options and customizable plate layout configurations.
DO YOU WANT TO KNOW MORE?
We know that time is an increasingly scarce resource, even in the lab. That's why we've thought your problem through and have everything ready for a complete one-handed solution.